Menu

Albany Molecular Research, Inc. AMRI

Full chart Compare
Set alert

Price alert · AMRI

All alert types
21.74 0.00 (+0.00%)

At closeJun 28, 2019, 6:07 PM EDT

21.73 Day range 21.76
13.01 52-week range 22.17

Revenue & Expenses

Revenue → Gross Profit: $132.80MGross Profit → Expenses: $132.80MRevenue → Cost of Revenue: $437.65MExpenses → Selling, General & Admin: $122.14MExpenses → Research & Development: $16.05MExpenses → Other Operating Expenses: $13.38MExpenses → Interest Expense: $39.92MExpenses → Other Expenses: $1.28MExpenses → Income Tax: $10.21MNet Loss → Expenses: $70.17MGross Profit$132.80MNet Loss$70.17MCost of Revenue$437.65MExpenses$202.97MSelling, General & Admin$122.14MResearch & Development$16.05MOther Operating Expenses$13.38MInterest Expense$39.92MOther Expenses$1.28MIncome Tax$10.21MRevenue$570.45M

Latest period ending Dec 31, 2016 · select a line to chart its full history

AMRI annual income statement
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012
570.45M402.36M276.57M246.57M226.69M
132.80M106.83M67.38M74.65M58.62M
-18.76M13.65M5.72M20.18M703.00K
-70.17M-2.30M-3.28M11.77M-4.26M
-1.83-0.07-0.100.37-0.14
AMRI annual balance sheet
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012
52.24M52.31M51.05M180.45M28.52M
1.21B865.57M515.87M445.27M262.86M
910.67M578.34M274.05M204.51M56.72M
640.91M389.28M156.34M124.16M8.00M
298.98M287.22M241.82M240.76M206.14M
AMRI annual cash flow
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012
26.64M39.63M1.91M28.18M15.34M
-193.20M-221.72M-163.26M-11.25M-9.78M
170.84M185.42M33.24M136.88M-2.53M
-50.74M-22.01M-17.11M-10.84M-9.44M
2.66M2.35M-128.93M152.63M3.31M